Tuberculosis contact tracing: confidentiality, stigma, and collective protection

Autores

Resumo

Tuberculosis remains a major public health challenge, particularly among vulnerable populations. Contact tracing and preventive treatment are essential to interrupt transmission, yet they also raise ethical dilemmas regarding confidentiality and stigma. This study reviewed and discussed these from a bioethical perspective. A narrative literature review was conducted in PubMed, SciELO, LILACS, and Google Scholar, including publications from 2015 to 2024 that examined ethical aspects of tuberculosis contact tracing. Nine studies met the inclusion criteria and indicated that, despite its relevance for disease control, contact tracing may expose individuals and reinforce stigmatization. Fear of discrimination contributed to withholding information and poor adherence to preventive treatment. Mitigation strategies include health education, empathetic communication, informed consent, privacy protection, and ethical training for health professionals. Ethical tuberculosis control requires balancing collective protection with respect for autonomy and human dignity.

Palavras-chave:

Latent tuberculosis. Contact tracing. Ethics, clinical. Confidentiality. Social stigma.

Biografia do Autor

Dinah Carvalho Cordeiro, Universidade Federal do Rio de Janeiro. Rio de Janeiro/RJ, Brasil.

Dinah Carvalho Cordeiro – Master – dinah.cordeiro.semsa@gmail.com
0000-0003-1830-8532

Tamiris Moraes Siqueira, Secretaria Municipal de Saúde de Manaus. Manaus/AM, Brasil.

Tamiris Moraes Siqueira – Master – tamirismsiqueira@gmail.com
0000-0002-4662-747X

Jonas Byk, Universidade Federal do Amazonas. Manaus/AM, Brasil.

Jonas Byk – PhD – jonas.byk@hotmail.com
0000-0001-5854-4316

Anete Trajman, Universidade Federal do Rio de Janeiro. Rio de Janeiro/RJ, Brasil.

Anete Trajman – PhD – atrajman@gmail.com
0000-0002-4000-4984

Referências

1. World Health Organization. Global Tuberculosis Report 2024 [Internet]. [cited 2025 Mar 28]. Available from: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024

2. Ministério da Saúde (BR). Manual de Recomendações para o Controle da Tuberculose no Brasil [Internet]. 2019 [cited 2025 Mar 31]. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/manual-de-recomendacoes-e-controle-da-tuberculose-no-brasil-2a-ed.pdf/view

3. Trajman A, Campbell JR, Kunor T, Ruslami R, Amanullah F, Behr MA, et al. Tuberculosis. The Lancet. 2025 Mar 8;405(10481):850–66.

4. Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J [Internet]. 2013 Jan 1 [cited 2023 Sep 19];41(1):140–56. Available from: https://europepmc.org/articles/PMC3533588

5. Fuady A, Arifin B, Yunita F, Rauf S, Fitriangga A, Sugiharto A, et al. Stigma, depression, quality of life, and the need for psychosocial support among people with tuberculosis in Indonesia: A multi-site cross-sectional study. PLOS Glob Public Health [Internet]. 2024 Jan 8 [cited 2025 Sep 24];4(1):e0002489. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10773931/

6. Courtwright A, Turner AN. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010;125(Suppl 4):34–42.

7. Craig GM, Daftary A, Engel N, O’Driscoll S, Ioannaki A. Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries. Int J Infect Dis. 2017 Mar;56:90–100.

8. Daftary A, Mitchell EMH, Reid MJA, Fekadu E, Goosby E. To End TB, First-Ever High-Level Meeting on Tuberculosis Must Address Stigma. Am J Trop Med Hyg [Internet]. 2018 Nov [cited 2025 Sep 24];99(5):1114–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6221214/

9. Rebeiro PF, Cohen MJ, Ewing HM, Figueiredo MC, Peetluk LS, Andrade KB, et al. Knowledge and stigma of latent tuberculosis infection in Brazil: implications for tuberculosis prevention strategies. BMC Public Health [Internet]. 2020 Jun 9 [cited 2025 Oct 2];20(1):897. Available from: https://doi.org/10.1186/s12889-020-09053-1

10. Basu S, Sharma N, Mase S, Sachdeva K. Ethical issues in expanding latent TB management in high burden countries. Indian J Med Ethics [Internet]. 2020 Feb 17 [cited 2025 Oct 2]; Available from: https://ijme.in/articles/ethical-issues-in-expanding-latent-tb-management-in-high-burden-countries/

11. Nagarajan K, Muniyandi M, Sellappan S, Karunanidhi S, Senthilkumar K, Palani B, et al. A study on tuberculosis disease disclosure patterns and its associated factors: Findings from a prospective observational study in Chennai. PLOS ONE [Internet]. 2023 Jan 26 [cited 2025 Oct 3];18(1):e0280812. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0280812

12. Szkwarko D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, Carr C, Mandalakas AM. Child contact management in high tuberculosis burden countries: a mixed-methods systematic review. PLoS ONE [Internet]. 2017 Aug 1 [cited 2025 Oct 2];12(8):e0182185. Available from: https://dx.plos.org/10.1371/journal.pone.0182185

13. Holzschuh EL, Province S, Johnson K, Walls C, Shemwell C, Martin G, et al. Use of Video Directly Observed Therapy for Treatment of Latent Tuberculosis Infection — Johnson County, Kansas, 2015. MMWR Morb Mortal Wkly Rep [Internet]. 2017 Apr 14 [cited 2025 Oct 2];66(14):387–9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5657805/

14. Faccini M, Cantoni S, Ciconali G, Filipponi MT, Mainardi G, Marino AF, et al. Tuberculosis-related stigma leading to an incomplete contact investigation in a low-incidence country. Epidemiol Infect [Internet]. 2015 Oct [cited 2025 Oct 2];143(13):2841–8. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9151128/

15. Spruijt I, Haile DT, van den Hof S, Fiekert K, Jansen N, Jerene D, et al. Knowledge, attitudes, beliefs, and stigma related to latent tuberculosis infection: a qualitative study among Eritreans in the Netherlands. BMC Public Health [Internet]. 2020 Oct 23 [cited 2025 Oct 3];20(1):1602. Available from: https://doi.org/10.1186/s12889-020-09697-z

16. Contact investigation in multidrug-resistant tuberculosis: ethical challenges [Internet]. [cited 2025 Oct 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/38430345/

17. Denholm JT, Millan-Marcelo JC, Fiekert K. Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives. Int J Tuberc Lung Dis. 2020 May 1;24(5):21–6.

18. World Health Organization. Guidance for managing ethical issues in infectious disease outbreaks [Internet]. Geneva: WHO; 2016 [cited 2025 Oct 22]. Available from: https://www.who.int/publications/i/item/9789241549837

19. Childress JF, Faden RR, Gaare RD, Gostin LO, Kahn J, Bonnie RJ, et al. Public health ethics: mapping the terrain. J Law Med Ethics. 2002;30(2):170–8.

Como Citar

1.
Carvalho Cordeiro D, Moraes Siqueira T, Byk J, Trajman A. Tuberculosis contact tracing: confidentiality, stigma, and collective protection. Rev. Bioét. [Internet]. 4º de novembro de 2026 [citado 4º de novembro de 2026];34. Disponível em: https://revistabioetica.cfm.org.br/revista_bioetica/article/view/4222